NCT02184416 2026-02-27
ADONIS
Pfizer
Completed
Clinical Trials
29 trialsNCT04763408 2024-07-18
STELLAR
Eisai Inc.
Completed
NCT05594147 2023-11-07
ROCURS
Bayer
Completed
NCT02303444 2023-06-08
RIFTOS MKI
Bayer
Completed
NCT04788420 2022-06-01
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML
Nanfang Hospital, Southern Medical University
Completed
NCT02973204 2021-04-28
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus
Completed
NCT04553458 2020-09-17
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Sohag University
Completed
NCT01933945 2018-11-06
OPTIMIS
Bayer
Completed
NCT01411423 2018-06-06
Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan
Bayer
Completed
NCT01412671 2018-06-06
Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program
Bayer
Completed
NCT01982097 2018-02-07
SANE
Bayer
Completed
NCT01839630 2017-12-20
SUCCESS
Bayer
Completed
NCT01728948 2017-11-09
Sorafenib in Elderly mRCC
Bayer
Completed
NCT02616692 2017-09-27
HCC Patient Preferences in Japan
Bayer
Completed
NCT01751763 2017-09-25
SECURE
Bayer
Completed
NCT01557127 2017-03-28
NEXST
Bayer
Completed
NCT00812175 2016-10-17
GIDEON
Bayer
Completed
NCT01576185 2016-05-17
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01539681 2016-02-18
STELLA
Bayer
Completed
NCT01908322 2015-11-11
SORINT
Bayer
Completed
NCT01012011 2015-09-21
Regulatory Post Marketing Surveillance Study on Nexavar®
Bayer
Completed
NCT01411436 2015-03-04
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
Bayer
Completed
NCT01508364 2015-01-21
NEXTAR
Bayer
Completed
NCT00792350 2014-05-14
INSIGHT
Bayer
Completed
NCT01449825 2014-04-21
Hepatic Monitoring for Pazopanib
GlaxoSmithKline
Completed
NCT01381601 2013-05-13
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
GlaxoSmithKline
Completed
NCT01381614 2013-05-13
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)
GlaxoSmithKline
Completed
NCT00771147 2012-06-15
PONDIAC
Bayer
Completed
NCT00895674 2010-09-30
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
Bayer
Completed